JAMD – Online il volume 29 – n. 2
Leggi
Whole-system trust in science, medicine, and public health
Dzau VJ, DeStefano L, Taylor SM
JAMA. Pub. online 25 Jun 2026.
Leggi
EMA: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
26 June 2026
Leggi
Positive recommendation on insulin efsitora alfa
25 June 2026
Leggi
Outcome of assessment on use of Mounjaro to reduce the risk of serious events affecting the heart and blood circulation
26 June 2026
Leggi
Postpartum body weight and cardiometabolic biomarker trajectories in women with gestational diabetes: a population-based matched cohort study
Abdulsalam R, Jebb SA, Michalopoulou M, et al.
Diabetes Obes Metab. Pub. online 22 Jun 2026.
Leggi
Comparative safety of lipid-lowering drugs alone or in combination: insights from a systematic review and network meta-analysis
Xie S, Galimberti F, Olmastroni E, et al.
Nutr Metab Cardiovasc Dis. Pub. online 23 Jun 2026.
Leggi
Hepatic safety of orforglipron in adults with obesity or overweight and/or type 2 diabetes: a pooled analysis of the orforglipron phase 3 clinical trials
Wharton S, Stefanski A, Chen J, et al.
Diabetes Obes Metab. Pub. online 23 Jun 2026.
Leggi
Whole-population trends in obesity across dimensions of inequality in England, 2019–25: a retrospective, longitudinal cohort study of 54 million adults
Fletcher RA, Conrad N, Rockenschaub P, et al.
Lancet Diabetes Endocrinol. Pub. online 24 Jun 2026.
Leggi